Compounds > n-formylmethionine leucyl-phenylalanine

n-formylmethionine leucyl-phenylalanine and angiotensin i

n-formylmethionine leucyl-phenylalanine has been researched along with angiotensin i in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaempfer, CE; Klickstein, LB; Wintroub, BU1
Andonegui, G; Geffner, JR; Giordano, M; López, DH; Nahmod, V; Raiden, S; Trevani, AS1

Other Studies

2 other study(ies) available for n-formylmethionine leucyl-phenylalanine and angiotensin i

ArticleYear
The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G.
    The Journal of biological chemistry, 1982, Dec-25, Volume: 257, Issue:24

    Topics: Angiotensin I; Cathepsin G; Cathepsins; Chemotactic Factors; Humans; Kinetics; Lysosomes; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Peptidyl-Dipeptidase A; Serine Endopeptidases

1982
Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formylmethionyl-leucyl-phenylalanine to neutrophil receptors.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 281, Issue:2

    Topics: Angiotensin I; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Humans; Imidazoles; Losartan; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Receptors, Angiotensin; Tetrazoles

1997